178 related articles for article (PubMed ID: 15467763)
1. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
[TBL] [Abstract][Full Text] [Related]
2. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.
Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
[TBL] [Abstract][Full Text] [Related]
3. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis.
Takai D; Yagi Y; Wakazono K; Ohishi N; Morita Y; Sugimura T; Ushijima T
Oncogene; 2001 Nov; 20(51):7505-13. PubMed ID: 11709722
[TBL] [Abstract][Full Text] [Related]
4. Identification of silencing of nine genes in human gastric cancers.
Kaneda A; Kaminishi M; Yanagihara K; Sugimura T; Ushijima T
Cancer Res; 2002 Nov; 62(22):6645-50. PubMed ID: 12438262
[TBL] [Abstract][Full Text] [Related]
5. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
[TBL] [Abstract][Full Text] [Related]
6. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
[TBL] [Abstract][Full Text] [Related]
7. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Furuta J; Nobeyama Y; Umebayashi Y; Otsuka F; Kikuchi K; Ushijima T
Cancer Res; 2006 Jun; 66(12):6080-6. PubMed ID: 16778180
[TBL] [Abstract][Full Text] [Related]
8. Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activation" (MeTA-array).
Shimizu H; Horii A; Sunamura M; Motoi F; Egawa S; Unno M; Fukushige S
Biochem Biophys Res Commun; 2011 Jul; 411(1):162-7. PubMed ID: 21723258
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
10. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M
Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440
[TBL] [Abstract][Full Text] [Related]
12. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.
Sato N; Fukushima N; Maitra A; Matsubayashi H; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Cancer Res; 2003 Jul; 63(13):3735-42. PubMed ID: 12839967
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
[TBL] [Abstract][Full Text] [Related]
17. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.
Hosoya K; Yamashita S; Ando T; Nakajima T; Itoh F; Ushijima T
Cancer Lett; 2009 Nov; 285(2):182-9. PubMed ID: 19527921
[TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
[TBL] [Abstract][Full Text] [Related]
19. Isolation and enrichment of human genomic CpG islands by methylation-sensitive mirror orientation selection.
Huang Q; Baum L; Huang JF; You JP; Wang F; Wang J; Zheng J; Yan XC; Xia H; Zhao YH; Kuang H; Fu WL
Anal Biochem; 2007 Jun; 365(2):153-64. PubMed ID: 17481566
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
